Centiva Capital, LP Horizon Therapeutics Public LTD CO Transaction History

Centiva Capital, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $1.22 Million - $1.43 Million	12,313 Added 4.64%	277,625 $32.1 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $18.3 Million - $21.4 Million	190,125 Added 252.87%	265,312 $27.3 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $5.09 Million - $5.38 Million	47,442 Added 170.99%	75,187 $8.21 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $1.6 Million - $2.91 Million	25,567 Added 1173.88%	27,745 $3.16 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $413,795 - $594,637	-7,023 Reduced 76.33%	2,178 $135,000

Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $730,559 - $1.07 Million	9,201 New	9,201 $734,000
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $1.29 Million - $1.55 Million	-14,036 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $1.21 Million - $1.35 Million	14,036 New	14,036 $1.31 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $837,701 - $1.06 Million	-12,503 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $690,540 - $999,364	12,503 New	12,503 $971,000
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $275,303 - $519,429	-9,116 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$24.87 - $38.56 $226,714 - $351,512	9,116 New	9,116 $270,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.